Skip to content

CLEfts and FEeding Difficulties (CLEFED-1): the effect and timing of surgical closure in children with cleft palate.

CLEfts and FEeding Difficulties (CLEFED-1): the effect and timing of surgical closure in children with cleft palate. - CLEFED-1

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39509
Enrollment
240
Registered
2012-01-10
Start date
2012-04-12
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft lip cleft palate

Interventions

Intervention: One group will undergo surgical closure between the age of 6-8 months and the other group between the age of 10-12 months. All patients will undergo this intervention following the sta

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Childeren born with a cleft lip and palate or cleft palate that visit the cleft team. Inclusion at the age of 5 months. Adequate understanding of the Dutch language by the parents Informed consent

Exclusion criteria

Exclusion criteria: Children that were adopted Children that are previous seen by another cleft-team (another hospital) No informed consent

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: the main study parameters of this study are: - feeding techniques and skills, defined by scores from Montreal Children*s Hospital Feeding scale (MCH), Nijmeegse Observatielijst Lepelvoeding (NOL) and an observation lists focussed on children with clefts. - weight gain (growth), defined by the difference in measurements (standard deviation) marked on a standardized growth-curve

Secondary

MeasureTime frame
Secondary parameters/endpoints: NS feeding (and duration), extent of the cleft palate, associated malformations, upper respiratory infections / pneumonia, medication (child), placement of grommets (middle ear tubes), complications/adverse effects

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)